Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04634643 · ClinicalTrials.gov registry record
Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
A clinical trial of NAFLD, sponsored by Yale University.
- Recruiting
- Registry status
- 260
- Enrollment target
- 1
- Study location
NCT04634643 is a study of NAFLD that is actively recruiting participants, run by Yale University. The registered enrollment target is 260 participants, above the 155-participant average among 26 other NAFLD trials with a reported enrollment target (68% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04634643, a study of NAFLD, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- 260 participants
- Enrollment target
- 1
- Study location
Study Summary
The main aim of the study is to discover the mechanisms underlying the pathophysiology of NAFLD in obese youth.
Conditions Studied
Interventions
- OTHER Usual diet and physical activity
Study Locations (1)
Connecticut
- Yale New Haven Hospital - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2021-06-28 |
| Est. Completion | 2026-01-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04634643
The ClinicalTrials.gov registry entry for NCT04634643 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 155-participant average among 26 other NAFLD trials with a reported enrollment target (68% higher). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with NAFLD appearing as the primary indexed condition, and to 1 intervention - of which Usual diet and physical activity is the first listed.
NCT04634643 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT04634643 about?
NCT04634643 is a clinical study titled "Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)". The main aim of the study is to discover the mechanisms underlying the pathophysiology of NAFLD in obese youth.
What is the current status of trial NCT04634643?
This trial is currently recruiting. The enrollment target is 260 participants. The study started on 2021-06-28. Estimated completion is 2026-01-30.
What conditions does trial NCT04634643 study?
This clinical trial studies the following conditions: NAFLD.
What interventions are being tested in trial NCT04634643?
The interventions under investigation include: Usual diet and physical activity (OTHER).
Who is sponsoring clinical trial NCT04634643?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04634643 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for NAFLD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
RECRUITING · Phase 2
-
Reversal of Lipid-Induced Insulin Resistance
RECRUITING · NA
-
Digoxin In NASH (CODIN)
RECRUITING · Phase 2
-
Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study)
RECRUITING · Phase 3
-
Bicalutamide Therapy in Young Women With NAFLD and PCOS
RECRUITING · Phase 1
-
Androgens and NAFLD Longitudinal Cohort Study
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.